Survival analysis showed that the tumor samples in the ESRP1-high (z-score ≥ 1.96; n = 56) sample group had significantly worse BCR-free survival and RFS compared to those in the ESRP1-low (z-score < 1.96; n = 359) sample group (p < 0.05). Here, BCR is linked to neoplasm.